Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 7,041–7,060 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

S-POTASSIUM CHLORIDE 2 MEQ/ML INJECTION CONC (PF) 5ml glass vial, Rx Only Red Mountain Compounding Rx.

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-PHENOL 6% INJ SOLN, Rx Only 10ml glass vial, Red Mountain Compounding Rx.

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-NANDROLONE DEC 200MG/ML MDV INJ in SESAME OIL, Rx Only, 10ml glass vial. Red Mountain Compounding Rx.

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-MIC 25/50/50MG/ML MDV SOLN, 30ml glass vial, Rx Only, Red Mountain Compounding RX.

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-METHYLCOBALAMIN 1,000MCG/ML MDV INJ; a) 10ml, b) 30 ml glass vial, Rx Only, Red mountain Compounding RX

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-MANGANESE CHLORIDE 0.1MG/ML MDV SOLN, 10 ML vial, Red Mountain Compounding Rx

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-MAGNESIUM SULFATE 500MG/ML (4MEQ/ML) MDV INJ SOLN, 30 ML vial, Red Mountain Compounding Rx

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-MAGNESIUM CHLORIDE 200MG/ML MDV INJ, 30 ml vial, Red Mountain Compounding Rx

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-LYSINE HCL 100MG/ML MDV, 30ML vial, Red Mountain Compounding Rx

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-LIDOCAINE HCL 1% / PHENYLEPHRINE1.5% (PF) INJ SOLN, 1ml syringe, Red Mountain Compounding Rx

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-LIDOCAINE HCL 1% MDV SOLN, 50ML Vial, Red Mountain Compounding Rx

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-LIDOCAINE HCL 2% INHALATION SOLN SYRINGES, 2ML syringe, Red Mountain Compounding Rx

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-LEVOCARNITINE 100MG/ML MDV INJ SOLN, 30ML vial, Red Mountain Compounding Rx

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-HYDROXYPROG CAPROATE 250MG/ML IN SESAME OIL INJ, 5ML glass vial, Red Mountain Compounding Rx

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-HYDROXOCOBALAMIN 10MG/ML MDV INJ SOL, 30 ML glass vial, Red Mountain Compounding Rx.

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-HYDROGEN PEROXIDE 3% (PF) 30ML glass vial, Red Mountain Compounding RX

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-HYDROCHLORIC ACID 2MG/ML INJ SOLN, 50 ML glass vial, Red Mountain Compounding RX

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-HYALURONIDASE 150U/ML INJ SOLN (PF), 5 ML vial, Red Mountain Compounding RX

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-HCG 1200U/ML MDV INJ SOLN; packaged in a) 5 ML, b) 10 ML, c) 30 ML glass vial. Red Mountain Compounding RX

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

S-GLYCERIN 72% INJECTION SOLN, 30ML glass vial, Red Mountain Compounding RX

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
August 12, 2019
Reported by FDA
November 13, 2019
Distribution
Nationwide in the USA

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.